Literature DB >> 16931269

Effects of yellow intraocular lenses on light-induced upregulation of vascular endothelial growth factor.

Yasuo Yanagi1, Yuji Inoue, Aya Iriyama, Woo-Dong Jang.   

Abstract

PURPOSE: To investigate the protective effect of a blue-light filtering intraocular lens (yellow IOL) (YA60BB, Hoya) and an ultraviolet (UV)-absorbing IOL (VA60BB, Hoya) on light-induced phototoxicity to retinal pigment epithelial (RPE) cells laden with the lipofuscin fluorophore A2E and on the production of vascular endothelial growth factor (VEGF) after light exposure.
SETTING: University of Tokyo, Tokyo, Japan.
METHODS: The A2E-laden ARPE-19 cells were exposed to white light and a UV-absorbing IOL or a blue-light filtering IOL was placed over the light beam. After 48 hours of irradiation, the viability of the cells was determined with WST-1 (a sodium salt of 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) assay, and the secreted protein level of VEGF was determined by enzyme-linked immunosorbent assay.
RESULTS: Without an IOL, the white-light exposure decreased cell viability to 28% of the nonirradiated control. Although the UV-absorbing IOL tended to reduce light-induced cell death, the decrease was not significant. However, the presence of the blue-light filtering IOL significantly attenuated light-induced cell damage, increasing cell viability to 42%. The secreted VEGF protein level increased 3.2-fold after the A2E-laden RPE cells were exposed to white light. In the presence of the UV-absorbing IOL, the VEGF protein level decreased, but not significantly. The presence of the blue-light filtering IOL significantly attenuated the upregulated VEGF expression compared to upregulation without an IOL.
CONCLUSION: This study supports the theory that a blue-light filtering IOL may be more protective against A2E-induced photochemical damage and inhibit more light-induced VEGF production than a conventional UV-absorbing IOL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931269     DOI: 10.1016/j.jcrs.2006.04.012

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  12 in total

1.  Measurements of transmission spectrums and estimation of retinal blue-light irradiance values of currently available clear and yellow-tinted intraocular lenses.

Authors:  Masaki Tanito; Tsutomu Okuno; Yoshihisa Ishiba; Akihiro Ohira
Journal:  Jpn J Ophthalmol       Date:  2011-11-19       Impact factor: 2.447

2.  Effect on contrast sensitivity after clear, yellow and orange intraocular lens implantation.

Authors:  Sabyasachi Bandyopadhyay; Mita Saha; Asim Chakrabarti; Abhik Sinha
Journal:  Int Ophthalmol       Date:  2015-08-19       Impact factor: 2.031

3.  Estimation of the melatonin suppression index through clear and yellow-tinted intraocular lenses.

Authors:  Ichiya Sano; Masaki Tanito; Tsutomu Okuno; Yoshihisa Ishiba; Akihiro Ohira
Journal:  Jpn J Ophthalmol       Date:  2014-04-29       Impact factor: 2.447

4.  The effect of yellow tinted intraocular lenses on the result of frequency doubling perimetry after cataract surgery.

Authors:  Jae-Yun Kim; Jin-A Choi; Kyung-Sun Na; Choun-Ki Joo
Journal:  Korean J Ophthalmol       Date:  2011-01-17

Review 5.  Ultraviolet or blue-filtering intraocular lenses: what is the evidence?

Authors:  S M Downes
Journal:  Eye (Lond)       Date:  2016-01-08       Impact factor: 3.775

Review 6.  Recent studies provide an updated clinical perspective on blue light-filtering IOLs.

Authors:  James A Davison; Anil S Patel; Joao P Cunha; Jim Schwiegerling; Orkun Muftuoglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-17       Impact factor: 3.117

Review 7.  Evidence for the Role of Blue Light in the Development of Uveal Melanoma.

Authors:  Patrick Logan; Miguel Bernabeu; Alberto Ferreira; Miguel N Burnier
Journal:  J Ophthalmol       Date:  2015-05-17       Impact factor: 1.909

8.  Blue-light filtering alters angiogenic signaling in human retinal pigmented epithelial cells culture model.

Authors:  Natalia Vila; Aya Siblini; Evangelina Esposito; Vasco Bravo-Filho; Pablo Zoroquiain; Sultan Aldrees; Patrick Logan; Lluis Arias; Miguel N Burnier
Journal:  BMC Ophthalmol       Date:  2017-11-02       Impact factor: 2.209

9.  Blue-violet light decreases VEGFa production in an in vitro model of AMD.

Authors:  Mélanie Marie; Pauline Gondouin; Delphine Pagan; Coralie Barrau; Thierry Villette; José Sahel; Serge Picaud
Journal:  PLoS One       Date:  2019-10-23       Impact factor: 3.240

10.  Removal of the blue component of light significantly decreases retinal damage after high intensity exposure.

Authors:  Javier Vicente-Tejedor; Miguel Marchena; Laura Ramírez; Diego García-Ayuso; Violeta Gómez-Vicente; Celia Sánchez-Ramos; Pedro de la Villa; Francisco Germain
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.